title: Response to "Timing of radiotherapy and outcome in patients receiving adjuvant endocrine therapy." (Int J Radiat Oncol Biol Phys 2011;80:398-402).
authors.forename: Pelagia G
authors.initials: PG
authors.lastname: Tsoutsou
authors.forename: Wendy
authors.initials: W
authors.lastname: Jeanneret Sozzi
authors.forename: Mahmut
authors.initials: M
authors.lastname: Ozsahin
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000532:radiotherapy*; D005260:Female; D006801:Humans; D015412:Mastectomy, Segmental; D009364:Neoplasm Recurrence, Local; D013629:Tamoxifen / Q000627:therapeutic use*
chemical_list: D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen